Imamura A, Mackenzie H S, Lacy E R, Hutchison F N, Fitzgibbon W R, Ploth D W
Department of Medicine, Medical University of South Carolina, Charleston, USA.
Kidney Int. 1995 May;47(5):1394-402. doi: 10.1038/ki.1995.196.
The effects of chronic angiotensin II (Ang II) receptor blockade (losartan) or converting enzyme inhibition (enalapril) on blood pressure (BP), urinary albumin excretion (Ualb V), renal histology and the hemodynamic and excretory function of the clipped and nonclipped kidneys were studied in two-kidney, one-clip (2-K 1-C) rats. One day after clipping the right renal artery, male Wistar rats were divided into three groups receiving: (1) losartan, 20 mg/kg/day (N = 7), (2) enalapril, 20 mg/kg/day (N = 8), or (3) no treatment (controls, N = 9) for three weeks. Both losartan and enalapril treatments maintained conscious BP at comparably lowered levels compared to control animals (116 +/- 6 mm Hg and 113 +/- 2 mm Hg vs. 188 +/- 11 mm Hg, respectively, P < 0.01). Treatment also prevented the increase in Ualb V, observed for the untreated group, three weeks after clipping (1.7 +/- 0.5 and 0.7 +/- 0.1 mg/24 hr vs. 17.8 +/- 7 mg/24 hr, respectively, P < 0.01). After three weeks of treatment, acute study of renal function during pentobarbital anesthesia revealed higher values of GFR and RPF and lowered vascular resistance for nonclipped kidneys from the losartan and enalapril groups compared to the corresponding kidneys from control animals. Despite the lower BP of both treated groups, clipped kidney GFR and RPF were unchanged compared to the control group. Ualb V for nonclipped kidneys from untreated rats was approximately 5- to 10-fold higher than in the nonclipped kidneys from the treated groups.(ABSTRACT TRUNCATED AT 250 WORDS)
在两肾一夹(2-K 1-C)大鼠中,研究了慢性血管紧张素II(Ang II)受体阻断(氯沙坦)或转换酶抑制(依那普利)对血压(BP)、尿白蛋白排泄(Ualb V)、肾脏组织学以及夹闭和未夹闭肾脏的血流动力学和排泄功能的影响。在夹闭右肾动脉一天后,将雄性Wistar大鼠分为三组,分别接受:(1)氯沙坦,20毫克/千克/天(N = 7),(2)依那普利,20毫克/千克/天(N = 8),或(3)不治疗(对照组,N = 9),持续三周。与对照动物相比,氯沙坦和依那普利治疗均使清醒血压维持在相当低的水平(分别为116±6毫米汞柱和113±2毫米汞柱,而对照组为188±11毫米汞柱,P < 0.01)。治疗还防止了夹闭三周后未治疗组观察到的Ualb V增加(分别为1.7±0.5和0.7±0.1毫克/24小时,而未治疗组为17.8±7毫克/24小时,P < 0.01)。治疗三周后,在戊巴比妥麻醉下对肾功能进行的急性研究显示,与对照动物相应肾脏相比,氯沙坦和依那普利组未夹闭肾脏的肾小球滤过率(GFR)和肾血浆流量(RPF)值更高,血管阻力更低。尽管两个治疗组的血压较低,但与对照组相比,夹闭肾脏的GFR和RPF未发生变化。未治疗大鼠未夹闭肾脏的Ualb V比治疗组未夹闭肾脏高约5至10倍。(摘要截断于250字)